April 10, 2017
3 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Wechsler talks about role of biologics in eosinophilic granulomatosis with polyangiitis
CLEVELAND — At the Biologics Therapies VII Summit, Michael E. Wechsler, MD, MMSc, professor of medicine and director of the Asthma Institute at National Jewish Health in Denver, spoke about eosinophilic granulomatosis with polyangiitis and the role of biologics, which include mepolizumab and reslizumab.